Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-16-137737

Chief Financial Officer bought 148,960 shares at an average $3.32 ($494,032)

From the SEC's structured data for this filing

Trades in this filing

Moran Sean F. · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-08-17 Purchase : show line 1 in the form +83,960 $3.19 $267,832 216,410 D
2016-08-18 Purchase : show line 2 in the form +65,000 $3.48 $226,200 281,410 D
Open-market purchases · 148,960 sh · avg $3.32 · $494,032
Loading xslF345X03/doc4.xml…